Heart Test Laboratories Inc
Research Heart Test Laboratories Inc (HSCS) on Bullrun: market cap USD 12.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHSCS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 12.89M
- Financial periodFY2026
- RevenueUSD 4.32K
- Revenue growth-0.7%
- Net income-USD 9.14M
- Free cash flow-USD 7.47M
- Gross margin59.1%
Valuation Snapshot
latest market cap is USD 12.89M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 4.32K | -USD 9.14M | -USD 7.47M | 59.1% | -3.48 | USD 1.66M | USD 3.94M | USD 226.06K |
| FY2025 | USD 4.35K | -USD 8.77M | -USD 7.42M | 56.8% | -9.34 | USD 1.10M | USD 2.99M | USD 205.17K |
| FY2024 | USD 18.60K | -USD 6.61M | -USD 6.13M | 67.3% | -18.74 | USD 5.81M | USD 1.04M | USD 7.32M |
| FY2023 | USD 5.15K | -USD 6.35M | -USD 5.79M | 45.7% | -80 | USD 1.66M | USD 1.57M | USD 230.56K |
| FY2022 | USD 14.37K | -USD 4.83M | -USD 3.65M | 45.1% | -1.45 | USD 918.26K | USD 6.16M | -USD 6.06M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 12.89M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.82M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.74M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 10.88M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 6.90M | n/a | n/a | n/a |
About Heart Test Laboratories Inc
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Heart Test Laboratories Inc's market cap?
Heart Test Laboratories Inc's market capitalization is USD 12.89M.
What does Heart Test Laboratories Inc do?
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.